GBA1 and Parkinson disease: The authors found that sphingolipid levels are altered in both brains and EVs from patients with LB disorders (which encompass PD, PD dementia, and dementia with LB), irrespective of the co-occurrence of glucocerebrosidase (GBA) gene mutations.